CancerFax
Mukhtar BMT in India
Patient Success Story

Mukhtar Mohammed

A 19-year-old from Ethiopia with severe aplastic anemia received a matched-donor bone marrow transplant in India. His younger brother was the donor, and today he works as a pharmacist.

19 years oldSevere Aplastic AnemiaAllogeneic Bone Marrow TransplantTreated in IndiaSuccessful Transplant & Recovery
Mukhtar BMT in India
verified_userShared with Family Consent
favoritePatient Success Story

Mukhtar Mohammed, a Patient with Severe Aplastic Anemia from Ethiopia

After a diagnosis of severe aplastic anemia, Mukhtar received an allogeneic bone marrow transplant in India with his younger brother as the donor. He engrafted on day 21 and has since made a full recovery.
person19 years old
biotechSevere Aplastic Anemia
scienceAllogeneic Bone Marrow Transplant
flight_takeoffTreated in India
check_circleSuccessful Transplant & Recovery
forum

Why the Family Contacted CancerFax

The family was facing several difficult questions at once: where to go for a transplant, whether a donor in the family would match, whether Mukhtar was fit for the procedure, and how to manage the practical side of treatment in another country. These were not things they could easily resolve on their own.

search
Which centres have real experience transplanting severe aplastic anemia?

Not every transplant unit has depth in aplastic anemia specifically. Identifying a centre with that track record needed specialist knowledge.

science
Was a fully HLA-matched family donor available?

The older brothers were only half-matched. Understanding what further testing was needed, and what the results meant, required clinical guidance.

translate
How does a family from Ethiopia arrange transplant care in India?

Medical visas, document preparation, language, and hospital communication all had to be coordinated before any travel could happen.

"We were told a transplant was the only cure, but we did not know where to go, or whether anyone in our family would be a match."β€” Mukhtar's family

support_agent

How CancerFax Helped

CancerFax helped the family bring the case together and reach a transplant centre. That meant organising the medical records, identifying a suitable hospital, coordinating communication with the transplant team, and supporting the practical steps of travelling to India for treatment.

folder_shared
Case File Organisation

The medical summary, bone marrow biopsy result, and HLA typing reports were compiled into a structured case file for the transplant team to review.

search
Hospital & Specialist Match

The BLK Centre for Bone Marrow Transplant in New Delhi, a centre with experience in aplastic anemia transplants, was identified as a suitable option for the case.

translate
Communication & Coordination

Communication between the family and the hospital team was managed throughout the medical-opinion and evaluation process.

flight_takeoff
Travel & Logistics Support

Guidance on medical visas, documentation, and accommodation helped the family plan the journey for Mukhtar and an accompanying attendant.

CancerFax did not provide clinical opinions or make treatment decisions. All clinical decisions were made by the transplant team at the BLK Centre for Bone Marrow Transplant, New Delhi, led by Dr. Dharma Choudhary, based on full medical evaluation of Mukhtar's case.
timeline

Mukhtar's Treatment Journey

Key steps from diagnosis to treatment and beyond.

Step 1
Step 1 β€” Diagnosis in Ethiopia

Mukhtar developed falling blood counts, and a bone marrow biopsy confirmed severe aplastic anemia. He was started on cyclosporine and tranexamic acid and followed on regular review.

Step 2
Step 2 β€” Limited Local Options

Supportive medication could stabilise his condition but not cure the marrow failure. His doctors advised that an allogeneic bone marrow transplant abroad offered the real chance at recovery.

Step 3
Step 3 β€” Contact with CancerFax and Case Review

The family reached out for help. CancerFax reviewed the reports, helped structure the case for transplant centres, and a medical opinion was obtained from the BLK Centre for Bone Marrow Transplant in New Delhi.

Step 4
Step 4 β€” Donor Search and HLA Typing

HLA testing showed the two older brothers were only haploidentical. Further testing of the younger siblings identified Mukhtar's 8-year-old younger brother as a full match across the tested loci, giving the family a suitable related donor for transplant.

Step 5
Step 5 β€” Travel, Evaluation and Pre-Transplant Work-up

The family arranged a medical visa and travelled to New Delhi. The transplant team carried out the pre-transplant work-up and confirmed the donor and treatment plan after evaluation.

Step 6
Step 6 β€” Transplant, Engraftment and Recovery

Mukhtar underwent an allogeneic bone marrow transplant using his younger brother as the donor. Engraftment was confirmed on day 21 after the transplant, and his blood counts recovered as he moved into the post-transplant monitoring period.

info
An important reminder

Every patient's treatment plan is individual. The pathway above describes this specific case β€” not a blueprint for others. Suitability for each treatment is determined by the treating clinical team based on each patient's individual clinical situation.

favorite

Where Mukhtar Is Today

Mukhtar made a full recovery after his transplant. His younger brother's marrow engrafted successfully on day 21, his blood counts returned to normal, and he was able to come off the transfusions and supportive medication he had depended on before.

Today, Mukhtar has completed his graduation and works as a pharmacist. He continues with routine follow-up, but his life has returned to a normal, healthy rhythm.

β€œ"He is healthy, he has finished his studies, and he is working now. That is everything we hoped for when we started this journey."”— Mukhtar's family

school

What Other Families Can Learn

Mukhtar's journey offers a few practical lessons for other families facing severe aplastic anemia and a donor search.

search
Severe aplastic anemia needs specialist transplant input early

When supportive medication is not enough, early review by a transplant centre helps families understand whether a curative transplant is possible.

biotech
Test the whole family for HLA matching

The older brothers were only half-matched. Wider family testing found a full match in a younger sibling, which changed the options available.

timer
Act while the patient is stable

Transfusion-dependent patients are vulnerable. Exploring transplant while the patient is still well enough to travel and undergo treatment matters.

translate
Cross-border transplant is manageable with support

Visas, documentation, and hospital communication can feel overwhelming, but coordinated navigation makes international care workable.

How CancerFax Can Support Your Family

If you or a loved one is facing a complex or relapsed cancer diagnosis β€” or you have been told that local options are limited β€” CancerFax can help you understand what may be possible and how to access it.

Related on CancerFax

quiz

Frequently Asked Questions

Yes. CancerFax can review medical reports, help with HLA donor matching questions, identify transplant centres with experience in aplastic anemia, and coordinate access and logistics for treatment abroad. You can share medical reports with our team for an initial review.

For many young patients, an allogeneic bone marrow transplant using a suitably HLA-matched donor is the main curative option. When no matched donor is available, immunosuppressive therapy such as ATG combined with cyclosporine may be considered instead. The right path is decided by the treating transplant team after full evaluation.

If a fully HLA-matched sibling is not available, transplant teams may consider haploidentical (half-matched) family donors, unrelated donor registries, or immunosuppressive therapy, depending on the patient. Wider family HLA testing is often the first step, as it was in Mukhtar's case, where a younger sibling turned out to be a full match. A specialist centre evaluates which option is safest and most suitable.

No. CancerFax is a patient navigation and treatment access platform. We help patients understand their options, identify suitable centres, prepare case files, and coordinate logistics. All clinical decisions are made by qualified medical specialists at the treating institution.

Yes. We encourage families to share medical reports early so our team can review the case and provide a clearer picture of what treatment may be possible β€” before any travel commitment is made. There is no cost for this initial review.

infoImportant Disclaimer

This patient story reflects an individual treatment journey. Outcomes vary from patient to patient. The information on this page should not be taken as medical advice or a guarantee of similar results. Treatment suitability depends on diagnosis, disease status, prior therapy, molecular findings, overall health, and specialist medical evaluation. Names and identifying details may be modified to protect patient privacy. All clinical decisions must be made in consultation with a qualified, licensed physician with access to the patient's complete medical information.

Need Help Understanding the Next Step?

If you or a loved one is facing a complex cancer diagnosis, relapse, or limited treatment options, CancerFax can help you organise the case, explore relevant hospitals and doctors, and understand whether advanced treatment or clinical trial pathways may be appropriate.

Β© CancerFax Β· Patient navigation and coordination platform. CancerFax is not a medical institution and does not provide medical treatment. All clinical care is provided by independent licensed physicians and hospitals. Patient names and identifying details are modified or anonymised where required to protect privacy. Story shared with documented family consent.